107 related articles for article (PubMed ID: 28481295)
1. Impaired geranylgeranyltransferase-I regulation reduces membrane-associated Rho protein levels in aged mouse brain.
Afshordel S; Wood WG; Igbavboa U; Muller WE; Eckert GP
J Neurochem; 2014 May; 129(4):732-42. PubMed ID: 24428713
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a Dual-Target Inhibitor of CDK7 and HDAC1 That Induces Apoptosis and Inhibits Migration in Colorectal Cancer.
Chen Y; Zhang S; Li Z; Yin B; Liu Y; Zhang L
ChemMedChem; 2023 Dec; 18(23):e202300281. PubMed ID: 37821774
[TBL] [Abstract][Full Text] [Related]
3. HIV-Nef Protein Transfer to Endothelial Cells Requires Rac1 Activation and Leads to Endothelial Dysfunction Implications for Statin Treatment in HIV Patients.
Chelvanambi S; Gupta SK; Chen X; Ellis BW; Maier BF; Colbert TM; Kuriakose J; Zorlutuna P; Jolicoeur P; Obukhov AG; Clauss M
Circ Res; 2019 Oct; 125(9):805-820. PubMed ID: 31451038
[TBL] [Abstract][Full Text] [Related]
4. Statins as anti-tumor agents: A paradigm for repurposed drugs.
Tripathi S; Gupta E; Galande S
Cancer Rep (Hoboken); 2024 May; 7(5):e2078. PubMed ID: 38711272
[TBL] [Abstract][Full Text] [Related]
5. The role of oxysterol binding protein-related protein 5 in pancreatic cancer.
Ishikawa S; Nagai Y; Masuda T; Koga Y; Nakamura T; Imamura Y; Takamori H; Hirota M; Funakosi A; Fukushima M; Baba H
Cancer Sci; 2010 Apr; 101(4):898-905. PubMed ID: 20128820
[TBL] [Abstract][Full Text] [Related]
6. Are statins onco- suppressive agents for every type of tumor? A systematic review of literature.
Filaferro L; Zaccarelli F; Niccolini GF; Colizza A; Zoccali F; Grasso M; Fusconi M
Expert Rev Anticancer Ther; 2024 Jun; 24(6):435-445. PubMed ID: 38609343
[TBL] [Abstract][Full Text] [Related]
7. Repurposing of the Cardiovascular Drug Statin for the Treatment of Cancers: Efficacy of Statin-Dipyridamole Combination Treatment in Melanoma Cell Lines.
Irie N; Mizoguchi K; Warita T; Nakano M; Sasaki K; Tashiro J; Osaki T; Ishikawa T; Oltvai ZN; Warita K
Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540310
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Novel Metalloenzyme Inhibitors Based on Property Characterization: Strategy and Application for HDAC1 Inhibitors.
Zhang L; Yang Y; Yang Y; Xiao Z
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474606
[TBL] [Abstract][Full Text] [Related]
9. An
Gopinathan A; Sankhe R; Rathi E; Kodi T; Upadhya R; Pai KSR; Kishore A
J Biomol Struct Dyn; 2024 Apr; ():1-14. PubMed ID: 38686917
[TBL] [Abstract][Full Text] [Related]
10. HDAC1/2 inhibitor therapy improves multiple organ systems in aged mice.
Tammaro A; Daniels EG; Hu IM; 't Hart KC; Reid K; Juni RP; Butter LM; Vasam G; Kamble R; Jongejan A; Aviv RI; Roelofs JJTH; Aronica E; Boon RA; Menzies KJ; Houtkooper RH; Janssens GE
iScience; 2024 Jan; 27(1):108681. PubMed ID: 38269100
[TBL] [Abstract][Full Text] [Related]
11. Unraveling the Anticancer Potential of Statins: Mechanisms and Clinical Significance.
Zaky MY; Fan C; Zhang H; Sun XF
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835481
[TBL] [Abstract][Full Text] [Related]
12. The Influence of Statin Use on Chemotherapeutic Efficacy in Studies of Mouse Models: A Systematic Review.
Tulk A; Watson R; Erdrich J
Anticancer Res; 2023 Oct; 43(10):4263-4275. PubMed ID: 37772570
[TBL] [Abstract][Full Text] [Related]
13. Network Analysis Reveals the Molecular Bases of Statin Pleiotropy That Vary with Genetic Background.
Del Rio Hernandez CE; Campbell LJ; Atkinson PH; Munkacsi AB
Microbiol Spectr; 2023 Mar; 11(2):e0414822. PubMed ID: 36946734
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between Statins and Cancer Prevention and Therapy: An Update.
Grabarek BO; Boroń D; Morawiec E; Michalski P; Palazzo-Michalska V; Pach Ł; Dziuk B; Świder M; Zmarzły N
Pharmaceuticals (Basel); 2021 Nov; 14(12):. PubMed ID: 34959621
[TBL] [Abstract][Full Text] [Related]
15. HDAC1: an environmental sensor regulating endothelial function.
Dunaway LS; Pollock JS
Cardiovasc Res; 2022 Jun; 118(8):1885-1903. PubMed ID: 34264338
[TBL] [Abstract][Full Text] [Related]
16. An Aptamer-Based Antagonist against the Receptor for Advanced Glycation End-Products (RAGE) Blocks Development of Colorectal Cancer.
Zheng J; Zhu W; He F; Li Z; Cai N; Wang HH
Mediators Inflamm; 2021; 2021():9958051. PubMed ID: 34035661
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting HDAC1 Enhances the Anti-Cancer Effects of Statins through Downregulation of GGTase-Iβ Expression.
Li R; Gan YH
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28481295
[TBL] [Abstract][Full Text] [Related]
18. Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer.
Wei TT; Lin YT; Chen WS; Luo P; Lin YC; Shun CT; Lin YH; Chen JB; Chen NW; Fang JM; Wu MS; Yang KC; Chang LC; Tai KY; Liang JT; Chen CC
EBioMedicine; 2016 Aug; 10():124-36. PubMed ID: 27448759
[TBL] [Abstract][Full Text] [Related]
19. DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers.
Lin YC; Lin YC; Shih JY; Huang WJ; Chao SW; Chang YL; Chen CC
Clin Cancer Res; 2015 Jan; 21(2):428-38. PubMed ID: 25593344
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
